Explore

Trendline Trendline
DiaMedica Therapeutics to Engage in 2026 RBC Capital Markets Global Healthcare Conference

DiaMedica Therapeutics to Engage in 2026 RBC Capital Markets Global Healthcare Conference

DiaMedica Therapeutics to Engage in 2026 RBC Capital Markets Global Healthcare Conference
Trendline Trendline
Dyno Therapeutics Unveils New AAV Capsids and AI Platform for Rare Disease Therapies

Dyno Therapeutics Unveils New AAV Capsids and AI Platform for Rare Disease Therapies

Dyno Therapeutics Unveils New AAV Capsids and AI Platform for Rare Disease Therapies
Trendline Trendline
AIRNA Unveils Promising Preclinical Data on RNA-Editing Therapeutics

AIRNA Unveils Promising Preclinical Data on RNA-Editing Therapeutics

AIRNA Unveils Promising Preclinical Data on RNA-Editing Therapeutics
Trendline Trendline
Contineum Therapeutics to Present at RBC Capital Markets Global Healthcare Conference

Contineum Therapeutics to Present at RBC Capital Markets Global Healthcare Conference

Contineum Therapeutics to Present at RBC Capital Markets Global Healthcare Conference
Trendline Trendline
Serif Biomedicines Unveils Modified DNA Platform to Overcome Therapeutic Barriers

Serif Biomedicines Unveils Modified DNA Platform to Overcome Therapeutic Barriers

Serif Biomedicines Unveils Modified DNA Platform to Overcome Therapeutic Barriers
Trendline Trendline
Serif Biomedicines Unveils Modified DNA Platform at ASGCT 2026 for Genetic Medicines

Serif Biomedicines Unveils Modified DNA Platform at ASGCT 2026 for Genetic Medicines

Serif Biomedicines Unveils Modified DNA Platform at ASGCT 2026 for Genetic Medicines
Trendline Trendline
Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments

Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments
Trendline Trendline
Spruce Biosciences Reports Financial Results and Advances TA-ERT Program for MPS IIIB

Spruce Biosciences Reports Financial Results and Advances TA-ERT Program for MPS IIIB

Spruce Biosciences Reports Financial Results and Advances TA-ERT Program for MPS IIIB
Trendline Trendline
DiaMedica Therapeutics CEO to Present at RBC Capital Markets Global Healthcare Conference

DiaMedica Therapeutics CEO to Present at RBC Capital Markets Global Healthcare Conference

DiaMedica Therapeutics CEO to Present at RBC Capital Markets Global Healthcare Conference
Trendline Trendline
DiaMedica Therapeutics to Present at RBC Capital Markets Global Healthcare Conference

DiaMedica Therapeutics to Present at RBC Capital Markets Global Healthcare Conference

DiaMedica Therapeutics to Present at RBC Capital Markets Global Healthcare Conference
Trendline Trendline
Palatin Reports Reduced Net Loss and Advances Obesity Programs

Palatin Reports Reduced Net Loss and Advances Obesity Programs

Palatin Reports Reduced Net Loss and Advances Obesity Programs
Trendline Trendline
Vertex Pharmaceuticals to Engage in Key Investor Conferences in May 2026

Vertex Pharmaceuticals to Engage in Key Investor Conferences in May 2026

Vertex Pharmaceuticals to Engage in Key Investor Conferences in May 2026